acetazolamide has been researched along with Apnea, Central in 16 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
Excerpt | Relevance | Reference |
---|---|---|
"Acetazolamide has been used to attenuate Hunter-Cheyne-Stokes breathing with central sleep apnea (CSA) associated with heart failure." | 9.19 | Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure. ( Edwards, BA; Javaheri, S; Sands, SA, 2014) |
"To determine the therapeutic efficacy of acetazolamide on central sleep apnea associated with heart failure." | 9.12 | Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. ( Javaheri, S, 2006) |
"Acetazolamide has been used to attenuate Hunter-Cheyne-Stokes breathing with central sleep apnea (CSA) associated with heart failure." | 5.19 | Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure. ( Edwards, BA; Javaheri, S; Sands, SA, 2014) |
"To determine the therapeutic efficacy of acetazolamide on central sleep apnea associated with heart failure." | 5.12 | Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study. ( Javaheri, S, 2006) |
"To further our understanding of central sleep apnea (CSA) at high altitude during acclimatization, we tested the hypothesis that pharmacologically altering cerebral blood flow (CBF) would alter the severity of CSA at high altitude." | 2.79 | Influence of cerebral blood flow on central sleep apnea at high altitude. ( Ainslie, PN; Basnyat, R; Burgess, KR; Dawson, A; Donnelly, J; Lucas, RA; Lucas, SJ; Peebles, KC; Shepherd, K; Swart, M; Thomas, KN, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 3 (18.75) | 2.80 |
Authors | Studies |
---|---|
Rocha, A | 1 |
Pinto, ACPN | 1 |
Pachito, DV | 1 |
Drager, LF | 1 |
Lorenzi-Filho, G | 1 |
Atallah, ÁN | 1 |
Naghan, PA | 1 |
Raeisi, K | 1 |
Khoundabi, B | 1 |
Foroughi, M | 1 |
Malekmohammad, M | 1 |
Mohebbi, M | 1 |
Bagheri, A | 1 |
Fahimi, F | 1 |
Brown, LK | 1 |
Netzer, N | 1 |
Netzer, PG | 1 |
Hanika, KS | 1 |
Pramsohler, S | 1 |
Eliasson, AH | 1 |
Kitamura, T | 1 |
Miyazaki, S | 1 |
Kadotani, H | 1 |
Kanemura, T | 1 |
Okawa, M | 1 |
Tanaka, T | 1 |
Komada, I | 1 |
Hatano, T | 1 |
Suzuki, H | 1 |
Javaheri, S | 2 |
Sands, SA | 1 |
Edwards, BA | 1 |
Burgess, KR | 1 |
Lucas, SJ | 1 |
Shepherd, K | 1 |
Dawson, A | 1 |
Swart, M | 1 |
Thomas, KN | 1 |
Lucas, RA | 1 |
Donnelly, J | 1 |
Peebles, KC | 1 |
Basnyat, R | 1 |
Ainslie, PN | 1 |
Gaffney, C | 1 |
McNally, P | 1 |
Bekfani, T | 1 |
Abraham, WT | 1 |
Badr, S | 1 |
Glidewell, RN | 1 |
Orr, WC | 1 |
Imes, N | 1 |
SERIFF, NS | 1 |
Yasuma, F | 1 |
Murohara, T | 1 |
Hayano, J | 1 |
Sanner, B | 1 |
Schäfer, T | 1 |
Grunstein, RR | 1 |
Hedner, J | 1 |
Grote, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Acetazolamide on Central Sleep Apnea Related to Opium Consumption[NCT02371473] | Phase 4 | 12 participants (Anticipated) | Interventional | 2014-11-30 | Enrolling by invitation | ||
Impact of Oxygen Therapy on Readmissions of Patients With Chronic Heart Failure With Reduced Ejection Fraction[NCT05913739] | 36 participants (Anticipated) | Interventional | 2023-07-01 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 reviews available for acetazolamide and Apnea, Central
Article | Year |
---|---|
Pharmacological treatment for central sleep apnoea in adults.
Topics: Acetazolamide; Adult; Aged; Apnea; Buspirone; Carbonic Anhydrase Inhibitors; Disorders of Excessive | 2023 |
Current and future developments in the field of central sleep apnoea.
Topics: Acetazolamide; Cardiac Resynchronization Therapy; Cheyne-Stokes Respiration; Continuous Positive Air | 2016 |
Central sleep apnea in patients with congestive heart failure.
Topics: Acetazolamide; Anticonvulsants; Bronchodilator Agents; Cheyne-Stokes Respiration; Heart Failure; Hum | 2009 |
[Central sleep apnea syndrome].
Topics: Acetazolamide; Altitude Sickness; Anticonvulsants; Bronchodilator Agents; Cardiovascular Diseases; C | 2008 |
Treatment options for sleep apnoea.
Topics: Acetazolamide; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Humans; Hypoxia; Positive- | 2001 |
4 trials available for acetazolamide and Apnea, Central
Article | Year |
---|---|
The effect of acetazolamide on the improvement of central apnea caused by abusing opioid drugs in the clinical trial.
Topics: Acetazolamide; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mi | 2020 |
Acetazolamide attenuates Hunter-Cheyne-Stokes breathing but augments the hypercapnic ventilatory response in patients with heart failure.
Topics: Acetazolamide; Aged; Blood Gas Analysis; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Chemorecepto | 2014 |
Influence of cerebral blood flow on central sleep apnea at high altitude.
Topics: Acclimatization; Acetazolamide; Administration, Intravenous; Administration, Oral; Adult; Altitude; | 2014 |
Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study.
Topics: Acetazolamide; Aged; Blood Gas Analysis; Cross-Over Studies; Diuretics; Double-Blind Method; Electro | 2006 |
7 other studies available for acetazolamide and Apnea, Central
Article | Year |
---|---|
Acetazolamide for central sleep apnea: teaching an old drug new tricks?
Topics: Acetazolamide; Humans; Pharmaceutical Preparations; Polysomnography; Sleep Apnea Syndromes; Sleep Ap | 2021 |
Pharmaceuticals are back in the Game for OSA Treatment : Highlights from the 2019 American Thoracic Society (ATS) Conference in Dallas, Texas, and 2019 Affiliated Professional Sleep Societies Meeting (APSS) in San Antonio, Texas.
Topics: Acetazolamide; Arousal; Attention; Blood Pressure; Carbon Dioxide; Continuous Positive Airway Pressu | 2019 |
Type I Chiari malformation presenting central sleep apnea.
Topics: Acetazolamide; Arnold-Chiari Malformation; Carbonic Anhydrase Inhibitors; Child; Decompression, Surg | 2014 |
Successful use of acetazolamide for central apnea in a child with Pitt-Hopkins syndrome.
Topics: Acetazolamide; Anticonvulsants; Facies; Humans; Hyperventilation; Intellectual Disability; Male; Pol | 2015 |
Acetazolamide as an adjunct to CPAP treatment: a case of complex sleep apnea in a patient on long-acting opioid therapy.
Topics: Acetazolamide; Administration, Cutaneous; Administration, Oral; Adult; Analgesics, Opioid; Carbonic | 2009 |
ALVEOLAR HYPOVENTILATION WITH NORMAL LUNGS: THE SYNDROME OF PRIMARY OR CENTRAL ALVEOLAR HYPOVENTILATION.
Topics: Acetazolamide; Aminophylline; Carbon Dioxide; Humans; Hypnosis; Hypoventilation; Lung; Medulla Oblon | 1965 |
Long-term efficacy of acetazolamide on Cheyne-Stokes respiration in congestive heart failure.
Topics: Acetazolamide; Cheyne-Stokes Respiration; Diuretics; Heart Failure; Humans; Sleep Apnea, Central; Tr | 2006 |